A subchorionic hematoma is a collection of blood that forms between the chorion and the amnion, two of the fetal membranes that surround the fetus. It is a common complication of pregnancy, and it can occur in up to 10% of all pregnancies. While the majority of these hematomas resolve by themselves, some can become large and can cause complications. It is important for obstetricians to be aware of the potential risks and to chart the course of the hematoma size in order to determine the best course of action for the patient.
A subchorionic hematoma is a collection of blood that forms between the chorion and the amnion, two of the fetal membranes that surround the fetus. It is also known as a subchorionic hemorrhage, subchorionic bleed, or subchorionic collection. It is a common complication of pregnancy, and it can occur in up to 10% of all pregnancies. The hematoma is usually caused by a tear in the placenta, which is the organ that provides the fetus with oxygen and nutrients. The tear can be caused by trauma, such as a car accident, or it can occur spontaneously. The hematoma can range in size from a few millimeters to several centimeters.
Subchorionic hematomas are usually diagnosed during an ultrasound. The ultrasound will show a collection of fluid between the chorion and the amnion. The size of the hematoma will be measured and monitored over time to determine if it is getting larger or smaller. If the hematoma is small and is not causing any symptoms, it can usually be monitored without any intervention. The patient should be advised to rest and avoid any activities that could increase the risk of trauma to the uterus. If the hematoma is large, the patient may be placed on bed rest and medications may be prescribed to reduce the risk of preterm labor. If the hematoma is very large, the patient may be referred to a maternal-fetal medicine specialist for further evaluation and management.
Subchorionic hematomas can cause complications, such as preterm labor, placental abruption, and fetal growth restriction. The risk of these complications increases with the size of the hematoma. The risk of preterm labor is increased if the hematoma is larger than 20 millimeters. Placental abruption is a serious condition in which the placenta separates from the uterus, and it is more likely to occur if the hematoma is larger than 30 millimeters. Fetal growth restriction is a condition in which the fetus does not grow at the expected rate, and it is more likely to occur if the hematoma is larger than 40 millimeters.
It is important for obstetricians to chart the course of the hematoma size in order to determine the best course of action for the patient. The size of the hematoma should be measured at each ultrasound, and the measurements should be compared to the previous measurements. The rate of growth should also be monitored, as this can help to determine if the hematoma is increasing in size or not. If the hematoma is increasing in size, the patient should be closely monitored and any interventions should be considered. If the hematoma is decreasing in size, the patient should be monitored for any signs of complications and the patient should be advised to rest and avoid any activities that could increase the risk of trauma to the uterus.
Subchorionic hematomas are a common complication of pregnancy, and they can cause serious complications if they become large. It is important for obstetricians to be aware of the potential risks and to chart the course of the hematoma size in order to determine the best course of action for the patient. If the hematoma is increasing in size, the patient should be closely monitored and any interventions should be considered. If the hematoma is decreasing in size, the patient should be monitored for any signs of complications and the patient should be advised to rest and avoid any activities that could increase the risk of trauma to the uterus.
1.
Belgian Algorithm Reshapes Endometrial Cancer Care
2.
ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer
3.
Nuclear missile workers are contracting cancer: They blame the bases
4.
On all CAR-T products, the FDA is calling for a new boxed warning.
5.
ASCO Future Focus: Metastatic Breast Cancer: Future Focus from the American Society of Clinical Oncology
1.
Understanding SVR Normal Range: A Guide to Achieving Optimal Health
2.
Consensus Recommendations for Healthy Hematologic Aging
3.
The Role of Alanine Aminotransferase in Liver Health and Disease
4.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
5.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation